Cue Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Cue Advisory Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,194	Closed	-$568K	–	157
2017 Q2	$568K	Sell	10,194 -235	-2%	-$12.8K	0.41%	88
2017 Q1	$567K	Sell	10,429 -35	-0.3%	-$1.92K	0.43%	83
2016 Q4	$612K	Buy	10,464 +120	+1%	+$6.56K	0.5%	77
2016 Q3	$558K	Buy	10,344 +358	+4%	+$23K	0.47%	83
2016 Q2	$734K	Sell	9,986 -75	-0.7%	-$5.3K	0.63%	62
2016 Q1	$643K	Sell	10,061 -890	-8%	-$56.1K	0.56%	74
2015 Q4	$753K	Sell	10,951 -1,283	-10%	-$84.8K	0.68%	59
2015 Q3	$724K	Buy	12,234 +815	+7%	+$51.7K	0.75%	54
2015 Q2	$760K	Buy	11,419 +48	+0.4%	+$3.16K	0.72%	59
2015 Q1	$732K	Sell	11,371 -524	-4%	-$32.8K	0.74%	53
2014 Q4	$702K	Buy	+11,895	New	+$671K	0.74%	55

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cue Advisory Services's BMY Position: Q3 2017 in Review

Cue Advisory Services sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 10,194 shares — an estimated $568K sold.

Cue Advisory Services first reported a position in BMY in Q4 2014 and held it in 11 quarters. The position peaked at $760K in Q2 2015. 1,642 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

Cue Advisory Services reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
Cue Advisory Services sold 10,194 Bristol-Myers Squibb shares in Q3 2017, an estimated $568K.
Cue Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 11 quarters.
Cue Advisory Services's Bristol-Myers Squibb position peaked at $760K in Q2 2015.
1,642 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Cue Advisory Services's 13F filing for Q3 2017, filed 24 Oct 2017.